Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029–30.

Article  PubMed  Google Scholar 

World Health Organization (WHO). (2020) Global Health Estimates 2020 deaths by cause, age, sex, by country and by region, 2000–2019. World Health Organization, Geneva. - references - scientific research publishing. 2022 [cited 2022 Aug 7]. Available from: https://www.scirp.org/reference/referencespapers.aspx?referenceid=3188789.

Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53.

Article  CAS  PubMed  Google Scholar 

Sharma S. Fighting cancer with cheap treatment and screening. Hindustan Times, New Delhi. 2018 Sep 23 [cited 2022 August 7]. Available from: https://www.hindustantimes.com/health/fighting-cancer-with-cheap-treatment-and-screening/story-GbPF7x8Nb6Z15TWurEppNK.html.

Mallath MK, Taylor DG, Badwe RA, Rath GK, Shanta V, Pramesh CS, Digumarti R, Sebastian P, Borthakur BB, Kalwar A, Kapoor S. The growing burden of cancer in India: epidemiology and social context. Lancet Oncol. 2014;15(6):e205–12.

Article  PubMed  Google Scholar 

Gupta A, Shridhar K, Dhillon PK. A review of breast cancer awareness among women in India: Cancer literate or awareness deficit? Eur J Cancer. 2015;51(14):2058–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tripathi N, Kadam YR, Dhobale RV, Gore AD. Barriers for early detection of cancer amongst Indian rural women. South Asian Journal of Cancer. 2014;3(02):122–7.

Article  PubMed  PubMed Central  Google Scholar 

Nyblade L, Stockton M, Travasso S, Krishnan S. A qualitative exploration of cervical and breast cancer stigma in Karnataka, India. BMC Womens Health. 2017;17(1):1–5.

Article  Google Scholar 

Palat G, Stenlander C, Jacob J, Sinha S, Rapelli V, Wiebe T, Brun E, Segerlantz M. Specialized palliative care and the quality of life for hospitalized cancer patients at a low-resource hospital in India. Indian J Palliat Care. 2018;24(3):289.

PubMed  PubMed Central  Google Scholar 

Pramesh CS, Badwe RA, Borthakur BB, Chandra M, Raj EH, Kannan T, Kalwar A, Kapoor S, Malhotra H, Nayak S, Rath GK. Delivery of affordable and equitable cancer care in India. Lancet Oncol. 2014;15(6):e223–33.

Article  CAS  PubMed  Google Scholar 

Rajpal S, Kumar A, Joe W. Economic burden of cancer in India: evidence from cross-sectional nationally representative household survey, 2014. PLoS ONE. 2018;13(2):e0193320.

Article  PubMed  PubMed Central  Google Scholar 

Singh M, Prasad CP, Singh TD. Lalit,*. Cancer Research in India: challenges & opportunities. Indian J Medicl Res. October 2018;148(4):362–5. https://doi.org/10.4103/ijmr.IJMR_171_18.

Hebert JR, Ghumare SS, Gupta PC. Stage at diagnosis and relative differences in breast and prostate cancer incidence in India: comparison with the United States. Asian Pac J Cancer Prev. 2006;7(4):547.

PubMed  Google Scholar 

Pakseresht S, Ingle GK, Garg S, Sarafraz N. Stage at diagnosis and delay in seeking medical care among women with breast cancer, Delhi, India. Iran Red Crescent Med J. 2014;16(12).

Smyth EN, Shen W, Bowman L, Peterson P, John W, Melemed A, Liepa AM. Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer. Health Qual Life Outcomes. 2016;14(1):1–0.

Article  Google Scholar 

Arboe B, Goerloev JS, Olsen MH, Dalton SO, Nielsen KF, Nielsen SR, Madsen C, de Nielsen R. Nully Brown P. Social outcomes after high dose chemotherapy with autologous stem cell transplant. Blood. 2016;128(22):1193.

Article  Google Scholar 

Wang H, Manca A, Crouch S, Bagguley T, Yu G, Aas E, Howell D, Burton C, Patmore R, Roman E, Smith A. PCN351-HEALTH-STATE UTILITY VALUES IN DIFFUSE LARGE B-CELL LYMPHOMA. Value in Health. 2018;21:74.

Article  Google Scholar 

Kelly JL, Pandya C, Friedberg JW, Mohile SG. Health-related quality of life in older patients following diffuse large B-cell lymphoma (DLBCL) diagnosis. Blood. 2012;120(21):4287.

Article  Google Scholar 

Efficace F, Gaidano G, Lo-Coco F. Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice? Blood the Journal of the American Society of Hematology. 2017;130(7):859–66.

CAS  Google Scholar 

Au HJ, Ringash J, Brundage M, Palmer M, Richardson H, Meyer RM. Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG. Expert Rev PharmacoEcon Outcomes Res. 2010;10(2):119–28.

Article  PubMed  Google Scholar 

US Department of Health and Human Services FDA Center for Drug Evaluation and Research laurie. burke@ fda. hhs. gov, US Department of Health and Human Services FDA Center for Biologics Evaluation and Research toni. stifano@ fda. hhs. gov, US Department of Health and Human Services FDA Center for Devices. and Radiological Health SXD@ cdrh. fda. gov. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health and Quality of Life Outcomes. 2006;4(1):79.

European Medicine Agency. The use of patient-reported outcome (PRO) measures in oncology studies. Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man.

Kluetz PG, Slagle A, Papadopoulos EJ, Johnson LL, Donoghue M, Kwitkowski VE, Chen WH, Sridhara R, Farrell AT, Keegan P, Kim G. Focusing on core patient-reported outcomes in cancer clinical trials: symptomatic adverse events, physical function, and disease-related symptoms. Clin Cancer Res. 2016;22(7):1553–8.

Article  CAS  PubMed  Google Scholar 

Basch E, Geoghegan C, Coons SJ, Gnanasakthy A, Slagle AF, Papadopoulos EJ, Kluetz PG. Patient-reported outcomes in cancer drug development and US regulatory review: perspectives from industry, the Food and Drug Administration, and the patient. JAMA Oncol. 2015;1(3):375–9.

Article  PubMed  Google Scholar 

Cella D, Webster K, Cashy J, Kutikova L, Burgess MF, Lin BK, Bowman L, Liepa AM, Gauthier JE, Gregory SA, Johnson SA. Development of a measure of Health-Related Quality of Life for Non-hodgkin’s Lymphoma Clinical Research: The Functional Assessment of Cancer Therapy-Lymphoma (FACT-Lym).

Brucker PS, Yost K, Cashy J, Webster K, Cella D. General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof. 2005;28(2):192–211.

Article  PubMed  Google Scholar 

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI: J Natl Cancer Inst. 1993;85(5):365–76.

Article  CAS  PubMed  Google Scholar 

Kind P. The EuroQol instrument. An index of health-related quality of life. Quality of life and pharmacoeconomics in clinical trials. 1996.

Department of Health Research. Health Technology Assessment in India– HTAIn. 2018. [cited August 7, 2022]. Available from: https://dhr.gov.in/sites/default/files/eNewsletter/img/HTAIn/HTAIn10-01-2017.pdf.

Pickard AS, Wilke CT, Lin HW, Lloyd A. Health utilities using the EQ-5D in studies of cancer. PharmacoEconomics. 2007;25(5):365–84.

Article  PubMed  Google Scholar 

Agarwal SK, Munjal M, Koul R, Agarwal R. Prospective evaluation of the quality of life of oral tongue cancer patients before and after the treatment. Ann Palliat Med. 2014;3(4):238–43.

PubMed  Google Scholar 

Barrios R, Bravo M, Gil-Montoya JA, Martínez-Lara I, García-Medina B, Tsakos G. Oral and general health-related quality of life in patients treated for oral cancer compared to control group. Health Qual Life Outcomes. 2015;13(1):1–8.

Article  Google Scholar 

Hassel AJ, Danner D, Freier K, Hofele C, Becker-Bikowski K, Engel M. Oral health-related quality of life and depression/anxiety in long-term recurrence-free patients after treatment for advanced oral squamous cell cancer. J Cranio-Maxillofacial Surg. 2012;40(4):e99–102.

Article  Google Scholar 

Indrapriyadharshini K, Madankumar PD, Karthikeyan GR. Oral health-related quality of life in patients treated for oral malignancy at Kanchipuram district, India: a cross-sectional study. Indian J Cancer. 2017;54(1):11.

Article  CAS  PubMed  Google Scholar 

Rogers SN, Semple C, Babb M, Humphris G. Quality of life considerations in head and neck cancer: United Kingdom National Multidisciplinary guidelines. J Laryngology Otology. 2016;130(S2):49–52.

Article  Google Scholar 

Borggreven PA, Verdonck-de Leeuw IM, Muller MJ, Heiligers ML, De Bree R, Aaronson NK, Leemans CR. Quality of life and functional status in patients with cancer of the oral cavity and oropharynx: pretreatment values of a prospective study. Eur Arch Otorhinolaryngol. 2007;264(6):651–7.

Article  PubMed  PubMed Central  Google Scholar 

Infante-Cossio P, Torres-Carranza E, Cayuela A, Gutierrez-Perez JL, Gili-Miner M. Quality of life in patients with oral and oropharyngeal cancer. Int J Oral Maxillofac Surg. 2009;38(3):250–5.

Article  CAS  PubMed  Google Scholar 

Visacri MB, Ferrari GB, Pimentel R, Ambrósio RD, Lima CS, Mazzola PG, Moriel P. Evaluation of the quality of life of patients before treatment of squamous cell carcinoma of the head and neck by means of chemoradiotherapy. Contemp Oncology/Współczesna Onkologia. 2015;19(2):148–53.

Article  PubMed  Google Scholar 

Prinja S, Dixit J, Gupta N, Mehra N, Singh A, Krishnamurthy MN, Gupta D, Rajsekar K, Kalaiyarasi JP, Roy PS, Malik PS. Development of national cancer database for cost and quality of life (CaDCQoL) in India: a protocol. BMJ open. 2021;11(7):e048513.

Article  PubMed  PubMed Central  Google Scholar 

Kaur S, Jain N, Bhatnagar PC. Early trends from Utilization of Oncology services: insights from Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PM-JAY). Working Paper 004. https://www.pmjay.gov.in/sites/default/files/2019-11/Working 20paper-4% 20% 281% 29. pdf; 2021.

Ramasubbu SK, Pasricha RK, Nath UK, Rawat VS, Das B. Quality of life and factors affecting it in adult cancer patients undergoing cancer chemotherapy in a tertiary care hospital. Cancer Rep. 2021;4(2):e1312.

Article  Google Scholar 

Jyani G, Sharma A, Prinja S, Kar SS, Trivedi M, Patro BK, Goyal A, Purba FD, Finch AP, Rajsekar K, Raman S. Development of an EQ-5D value set for India using an Extended Design (DEVINE) study: the Indian 5-Level version EQ-5D Value Set. Value in Health. 2022.

Prieto L, Sacristán JA. What is the value of social values? The uselessness of assessing health-related quality of life through preference measures. BMC Med Res Methodol. 2004;4(1):1–9.

Article  Google Scholar 

Rabin R, Charro FD. EQ-SD: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–43.

Article  CAS  PubMed  Google Scholar 

Jyani G, Prinja S, Kar SS, Trivedi M, Patro B, Purba F, Pala S, Raman S, Sharma A, Jain S, Kaur M. Valuing health-related quality of life among the Indian population: a protocol for the development of an EQ-5D value set for India using an extended design (DEVINE) study. BMJ open. 2020;10(11):e039517.

Article  PubMed  PubMed Central  Google Scholar 

Dhillon PK, Mathur P, Nandakumar A, Fitzmaurice C, Kumar GA, Mehrotra R, Shukla DK, Rath GK, Gupta PC, Swaminathan R, Thakur JS. The burden of cancers and their variations across the States of India: the global burden of Disease Study 1990–2016. Lancet Oncol. 2018;19(10):1289–306.

Article  Google Scholar 

New Delhi Television Ltd. (NDTV). 1300 Die of Cancer Every Day in India. 2015. [cited 2022 August 7]. Available from: